February 08, 2022
An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.
February 07, 2022
An oral presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.
February 04, 2022
An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.
February 04, 2022
In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.
February 04, 2022
Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.
February 04, 2022
At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.
February 03, 2022
Researchers presented their oral abstract on the association between lactation and the gut microbiome during the SMFM 42nd Annual Pregnancy Meeting.
February 03, 2022
At the 2022 virtual SMFM conference, a poster session highlighted a study on prenatal ultrasound findings in pregnant women with SARS-CoV-2 infection.
September 13, 2021
Registration is now open for the Society for Maternal-Fetal Medicine's (SMFM) 42nd Annual Pregnancy Meeting, to be held from January 31 to February 5, 2022, at the Gaylord Palms Resort and Convention Center near Orlando, Florida.
February 05, 2021
This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.